Terms ending in 2039
Millennium Pharmaceuticals, Inc.
Every in-force patent on Millennium Pharmaceuticals, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D1,010,817 | Autoinjector In force · High confidence | Millennium Pharmaceuticals, Inc. | In force | High confidence | |
| US 12,303,724 | Non-Adult Human Dosing of ANTI-CD30 Antibody-Drug Conjugates for Treatment of Hematological or Lymphoid Cancer In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,524,957 | PROCESS FOR THE SYNTHESIS OF 2-[(2S)-1-Azabicyclo[2.2.2]OCT-2-YL]-6-(3-Methyl-1H-PYRAZOL-4-YL)THIENO[3,2-d]PYRIMIDIN-4(3H)-ONE In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US D1,023,288 | Infusion Pump In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,498,708 | Systems and Methods for Filling Containers In force · High confidence | Millennium Pharmaceuticals, Inc. | In force | High confidence | |
| US 11,926,445 | Systems and Methods for Filling Containers In force · High confidence | Millennium Pharmaceuticals, Inc. | In force | High confidence | |
| US 12,384,572 | Systems and Methods for Filling Containers In force · High confidence | Millennium Pharmaceuticals, Inc. | In force | High confidence | |
| US 12,371,506 | Subcutaneous Administration of ANTI-CD38 Antibodies In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US D1,038,380 | Autoinjector In force · High confidence | Millennium Pharmaceuticals, Inc. | In force | High confidence | |
| US 11,746,109 | Crystalline Forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-one Hemihydrate In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| 2 more term ends in 2039 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
5 of these are in force and held by Millennium Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.